Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system

Mohammed Kashani–Sabet; James R. Miller; Serigne Lo; Mehdi Nosrati; Jonathan R. Stretch; Kerwin F. Shannon; Andrew J. Spillane; Robyn P.M. Saw; James E. Cleaver; Kevin B. Kim; Stanley P. L. Leong; John F. Thompson; Richard A Scolyer

doi:10.1002/cncr.33088

Related publications

Article2009

Prognostic impact of cancer-testis antigen expression in primary cutaneous melanoma

Jonathan Cebon, Šárka Svobodová, Jeffrey L. Browning, Ian D. Davis, Richard A Scolyer, Ramachandran Murali, John F. Thompson, Sumitra Deb, A. Azad, Duncan MacGregor

Article2017

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Jeffrey E. Gershenwald, Richard A Scolyer, Kenneth R. Hess, Vernon K. Sondak, Georgina V. Long, Merrick I. Ross, Alexander J. Lazar, Mark B. Faries, John M. Kirkwood, Grant A. McArthur, Lauren E. Haydu, Alexander M.M. Eggermont, Keith T. Flaherty, Charles M. Balch, John F. Thompson

Article2017

Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging

Tristan J. Dodds, Serigne Lo, Louise Jackett, Omgo E. Nieweg, John F. Thompson, Richard A Scolyer

Dataset

Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence

W Pruessmann, J Rytlewski, J Wilmott, M. C. Mihm, GH Attrill, B Dyring-Andersen, P Fields, Q Zhan, AJ Colebatch, PM Ferguson, John F. Thompson, K Kalenbach, E Yusko, Robert A. Clark, H Robins, Richard A Scolyer

Article2023

Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma

Elizabeth C. Paver, Tasnia Ahmed, Hazel Burke, Robyn P.M. Saw, Jonathan R. Stretch, Andrew J. Spillane, Kerwin F. Shannon, Ismael A. Vergara, David E. Elder, Serigne Lo, John F. Thompson, Richard A Scolyer